Kazumitsu Kanatani

Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer

Junichiro Watanabe, Yoshinori Ito, Toshiaki Saeki et al. · In Vivo · 2017 · 22 citations · Full text

A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer

Masahiro Kashiwaba, Yoshinori Ito, Shintaro Takao et al. · Japanese Journal of Clinical Oncology · 2016 · 21 citations · Full text

Involvement of stretch-activated cation channels in hypotonically induced insulin secretion in rat pancreatic β-cells

Miki Takii, Tomohisa Ishikawa, Hidetaka Tsuda et al. · American Journal of Physiology-Cell Physiology · 2006 · 18 citations

Rat Pancreatic β-Cells, Cellular Physiology, Insulin Signaling +19

Involvement of novel protein kinase C isoforms in carbachol-stimulated insulin secretion from rat pancreatic islets

Tomohisa Ishikawa, Eri Iwasaki, Kazumitsu Kanatani et al. · Life Sciences · 2005 · 18 citations

Signal Transduction, Molecular Physiology, Biochemistry +9

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial

Norikazu Masuda, Masato Takahashi, Kazuhiko Nakagami et al. · Japanese Journal of Clinical Oncology · 2017 · 11 citations · Full text